[Congress of the American Society of Clinical Oncology].
André
T
T
Service d'Oncologie Médicale, Hôpital Tenon - Paris, France.
D000230:Adenocarcinoma / Q000628:therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001650:Bile Duct Neoplasms / Q000628:therapy; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy; D004067:Digestive System Neoplasms / Q000628:therapy; D004938:Esophageal Neoplasms / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D008495:Medical Oncology; D020360:Neoadjuvant Therapy; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000628:therapy; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012955:Societies, Medical; D013274:Stomach Neoplasms / Q000628:therapy; D014481:United States
D000970:Antineoplastic Agents